niacinamide and arsenic
niacinamide has been researched along with arsenic in 12 studies
Research
Studies (12)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Morgenstern, N; Peters, L; Smith, JM | 1 |
Henderson, LM; Lan, SJ | 1 |
Francis, SH; Meriwether, BP; Park, JH | 1 |
Bechara, EJ; Cilento, G | 1 |
DIOGUARDI, N; VILLA, L | 1 |
Cui, YZ; Luo, RC; Wu, J; Zhang, H | 1 |
Bechelli, J; Ifthikharuddin, JJ; Jordan, CT; Liesveld, JL; Lu, C; Messina, P; Mulford, D; Phillips Ii, GL; Rosell, KE | 1 |
Allensworth, JL; Devi, GR; Diehl, AM; Lyerly, HK; Morse, MA; Rangwala, F; Smith, GR; Thomas, Z; Williams, KP | 1 |
He, C; Jiang, H; Jiang, X; Ma, L; Sun, X; Xu, L; Zhai, B; Zhao, D | 1 |
Chen, C; Hu, H; Li, H | 1 |
Goldberg, M; Hashim, P; Levitt, J; Verhave, B | 1 |
Chen, S; Cheng, W; He, T; Liu, J; Wang, X; Wang, Y; Zhang, J | 1 |
Trials
1 trial(s) available for niacinamide and arsenic
Article | Year |
---|---|
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Azacitidine; Benzenesulfonates; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cytarabine; Cytokines; Farnesyltranstransferase; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Niacinamide; Oxides; Phenylurea Compounds; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyridines; Sorafenib | 2011 |
Other Studies
11 other study(ies) available for niacinamide and arsenic
Article | Year |
---|---|
Inhibition of the renal tubular transport and excretion of tetraethylammonium and N1-methylnicotinamide by non-nitrogenous onium compounds.
Topics: Aminohippuric Acids; Animals; Antimony; Arsenic; Biological Transport; Carbon Isotopes; Chickens; Dogs; Kidney; Kidney Tubules; Niacinamide; Onium Compounds; Oxygen Consumption; Phosphorus; Receptors, Drug; Sulfur; Tetraethylammonium Compounds | 1967 |
Uptake of nicotinic acid and nicotinamide by rat erythrocytes.
Topics: Animals; Arsenicals; Biological Transport; Carbon Isotopes; Erythrocytes; Fluorides; Glucose; Iodoacetates; Niacinamide; Nicotinic Acids; Phosphates; Pyridines; Rats; Temperature; Time Factors | 1968 |
Interaction between adenine nucleotides and 3-phosphoglyceraldehyde dehydrogenase. II. A study of the mechanism of catalysis and metabolic control of the multi-functional enzyme.
Topics: Acetates; Acylation; Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arsenic; Autoradiography; Binding Sites; Carbon Isotopes; Catalysis; Chemical Phenomena; Chemistry; Cyclic AMP; Depression, Chemical; Diphosphates; Electrophoresis; Enzyme Activation; Glyceraldehyde-3-Phosphate Dehydrogenases; Guanine Nucleotides; Hydrogen-Ion Concentration; Hydrolysis; Muscles; NAD; Niacinamide; Nitrophenols; Nucleoside Diphosphate Sugars; Pepsin A; Peptides; Phosphoric Acids; Protein Binding; Rabbits; Ribose; Stimulation, Chemical | 1971 |
Phosphate catalysis in the autoxidation of 1-n-propyl-6-hydroxy-1,4,5,6-tetrahydronicotinamide. A model for adenosine triphosphate formation.
Topics: Adenosine Triphosphate; Aniline Compounds; Arsenic; Catalysis; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Chromatography, Paper; Deuterium; Kinetics; NAD; NADP; Niacinamide; Organophosphorus Compounds; Oxidation-Reduction; Oxygen Consumption; Phosphates; Phosphoric Acids; Potentiometry; Pyridinium Compounds; Spectrophotometry; Ultraviolet Rays | 1971 |
[Importance of the alimentation factor in liver respiration in rats in the presence of nicotinamide].
Topics: Animals; Arsenicals; Diet; Humans; Liver; Niacin; Niacinamide; Nicotinic Acids; Rats | 1954 |
[Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Niacinamide; Oxides; Phenylurea Compounds; Pyridines; Sorafenib | 2008 |
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
Topics: Adult; AMP-Activated Protein Kinases; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Activation; Fluorouracil; Gene Expression Regulation, Enzymologic; Growth Inhibitors; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Thymidylate Synthase; Time Factors | 2012 |
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Proteins; Niacinamide; Oxides; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib | 2015 |
[Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Sorafenib | 2015 |
Treatment of Arsenic-Induced Bowen’s Disease With Topical 5-Fluorouracil
Topics: Administration, Cutaneous; Administration, Oral; Antimetabolites, Antineoplastic; Arsenic; Bowen's Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorouracil; Humans; Middle Aged; Niacinamide; Skin Neoplasms; Water Pollutants; Water Supply | 2019 |
Integrated metabolomics and network pharmacology revealing the mechanism of arsenic-induced hepatotoxicity in mice.
Topics: Animals; Arsenic; Chemical and Drug Induced Liver Injury; Drugs, Chinese Herbal; Humans; Metabolomics; Mice; Network Pharmacology; Niacinamide; Phosphatidylinositol 3-Kinases | 2023 |